Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic

Authors: Etxeberria, Iñaki, Bolaños, Elixabet, Teijeira, Alvaro, Garasa, Saray, Yanguas, Alba, Azpilikueta, Arantza, Kavanaugh, William M., Vasiljeva, Olga, Belvin, Marcia, Howng, Bruce, Irving, Bryan, Tipton, Kimberly, West, James, Mei, Li, Korman, Alan J., Sega, Emanuela, Olivera, Irene, Cirella, Assunta, Ochoa, Maria C., Rodriguez, Maria E., Melero, Ana, Sanmamed, Miguel F., Engelhardt, John J., Melero, Ignacio

Source: Proceedings of the National Academy of Sciences of the United States of America, 2021 Jun . 118(26), 1-7.

Access URL: https://www.jstor.org/stable/27040814

Role of PD-1 during effector CD8 T cell differentiation

Authors: Ahn, Eunseon, Araki, Koichi, Hashimoto, Masao, Li, Weiyan, Riley, James L., Cheung, Jeanne, Sharpe, Arlene H., Freeman, Gordon J., Irving, Bryan A., Ahmed, Rafi

Source: Proceedings of the National Academy of Sciences of the United States of America, 2018 May 01. 115(18), 4749-4754.

Access URL: https://www.jstor.org/stable/26508751

Thymocyte Development in the Absence of Pre-T Cell Receptor Extracellular Immunoglobulin Domains

Authors: Irving, Bryan A., Alt, Frederick W., Killeen, Nigel

Source: Science, 1998 May 01. 280(5365), 905-908.

Access URL: https://www.jstor.org/stable/2896489

MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade

Authors: Ebert, Peter J.R., Cheung, Jeanne, Yang, Yagai, McNamara, Erin, Hong, Rebecca, Moskalenko, Marina, Gould, Stephen E., Maecker, Heather, Irving, Bryan A., Kim, Jeong M., Belvin, Marcia, Mellman, Ira

Source: In Immunity 15 March 2016 44(3):609-621

New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016

Authors: Adusumilli, Prasad, Cha, Edward, Cornfeld, Mark, Davis, Thomas, Diab, Adi, Dubensky, Thomas, Evans, Elizabeth, Grogan, Jane L., Irving, Bryan, Leidner, Rom, Olwill, Shane, Soon-Shiong, Patrick, Triebel, Frederic, Tuck, David, Bot, Adrian, Dansey, Roger, Drake, Charles, Freeman, Gordon, Ibrahim, Ramy, Patel, Salil, Chen, Daniel

Source: Journal for immunotherapy of cancer. 5(1):1-9

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100134206566.0x000001&indx=1&recIds=ETOCvdc_100134206566.0x000001

The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function

Authors: Johnston, Robert J., Comps-Agrar, Laetitia, Hackney, Jason, Yu, Xin, Huseni, Mahrukh, Yang, Yagai, Park, Summer, Javinal, Vincent, Chiu, Henry, Irving, Bryan, Eaton, Dan L., Grogan, Jane L.

Source: In Cancer Cell 8 December 2014 26(6):923-937

B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas

Authors: Affara, Nesrine I., Ruffell, Brian, Medler, Terry R., Gunderson, Andrew J., Johansson, Magnus, Bornstein, Sophia, Bergsland, Emily, Steinhoff, Martin, Li, Yijin, Gong, Qian, Ma, Yan, Wiesen, Jane F., Wong, Melissa H., Kulesz-Martin, Molly, Irving, Bryan, Coussens, Lisa M.

Source: In Cancer Cell 16 June 2014 25(6):809-821

Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors

Regulation of Interleukin-2 Gene Enhancer Activity by the T Cell Accessory Molecule CD28

Authors: Fraser, James D., Irving, Bryan A., Crabtree, Gerald R., Weiss, Arthur

Source: Science, 1991 Jan . 251(4991), 313-316.

Access URL: https://www.jstor.org/stable/2875267

Sequential Interactions of the TCR with Two Distinct Cytoplasmic Tyrosine Kinases

Authors: Iwashima, Makio, Irving, Bryan A., Chan, Andrew C., Weiss, Arthur

Source: Science, 1994 Feb . 263(5150), 1136-1139.

Access URL: https://www.jstor.org/stable/2883426

The ζ Chain is Associated with a Tyrosine Kinase and Upon T-Cell Antigen Receptor Stimulation Associates with ZAP-70, a 70-kDa Tyrosine Phosphoprotein

Authors: Chan, Andrew C., Irving, Bryan A., Fraser, James D., Weiss, Arthur

Source: Proceedings of the National Academy of Sciences of the United States of America, 1991 Oct . 88(20), 9166-9170.

Access URL: https://www.jstor.org/stable/2358106

Anti-PD-L1 antibodies, compositions and articles of manufacture

NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO

PDZ DOMAIN INTERACTIONS AND LIPID RAFTS

ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION

Novel Gene Disruptions, Compositions and Methods Relating Thereto

Methods of treating lupus using CD4 antibodies

Methods of treating lupus using CD4 antibodies

Intelligent machining workstation operating logic

Surface chimeric receptors as tools in study of lymphocyte activation

Authors: Irving, Bryan A., Weiss, Arthur

Source: In Methods in Enzymology 2000 327:210-228